U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey
about
Automated detection of off-label drug useOff-label use of sodium valproate for schizophreniaPharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.Assessing healthcare providers' knowledge and practices relating to insecticide-treated nets and the prevention of malaria in Ghana, Laos, Senegal and TanzaniaInsurance coverage policies for personalized medicine.Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.Clinically significant psychotropic drug-drug interactions in the primary care setting.Potential underuse, overuse, and inappropriate use of antidepressants in older veteran nursing home residents.Pivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002-2012Analyzing patterns of drug use in clinical notes for patient safetyOral Drugs for Unexplained InfertilitySurveying the Knowledge and Practices of Health Professionals in China, India, Iran, and Mexico on Treating TuberculosisOff-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.Automated Detection of Systematic Off-label Drug Use in Free Text of Electronic Medical RecordsUsing patients to promote evidence-based prescribing: comment on "Communicating uncertainties about prescription drugs to the public".Monitoring the safety of medicines used off-label.Off-label use of drugs and medical devices: a review of policy implications.Advances in the Pharmacogenomics of Adverse Drug Reactions.Off-label drug use in oncology: a systematic review of literature.Prescribing in palliative care: a quest for appropriateness.Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs.Off-label prescribing in older people: the need for increased awareness and caution.Return to play following injury: whose decision should it be?Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.A Patient-Centered Approach to Informed Consent: Results from a Survey and Randomized Trial.No evidence or no alternative? Taking responsibility for off-label prescribing.Going forth in July? Off-label use in psychiatry.Off-label prescribing of medications for pain: maintaining optimal care at an intersection of law, public policy, and ethicsOff-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors
P2860
Q28539923-08362CE8-BDDF-4502-B61B-8C06DF808AC5Q28541404-DE498C91-ECA3-4C7A-9925-34EC5E3714DEQ28552890-AD7D60D2-CE2F-4663-8513-FC331E85DC1DQ33647393-1121321A-CE03-43CA-A70E-D4DDAFD0CAD4Q34089761-A7296E66-F307-4A2E-A38D-5976E65168BEQ34099661-6A4D4EE2-9419-4279-A4E0-2D39044C169FQ34608654-DB976D7B-5620-4A4C-85F4-164D3878E742Q34680866-5660BCC1-6C69-4395-BDFD-1501C593B48EQ35104220-C088986E-1D9A-46AF-98BE-1A85E2C4C6ACQ35171130-247C59DB-3A0F-46DD-B325-73F21F184A37Q35691857-DD3D60FA-F966-4A8A-BEB4-92E233A15270Q36082925-6A74BC42-6960-48FF-9340-81ED8B41188CQ36586557-D6B62037-5E92-4E79-8694-C337DFF212F1Q36869629-7FDC2704-BEA5-462F-9E87-5FD0294FBF58Q37248061-3FD4DC3A-2C89-4DF7-8ECE-512D0221C4DEQ37271400-DFA62625-3B5E-4A4F-8C7A-C5D499FCF742Q37613623-0C1709AF-35F7-42C2-BBB5-7C6BE1C51439Q37999649-683D20C3-EC7B-43BB-8697-DA6CB0CB4BCAQ37999651-6E928EA0-216B-4962-8638-25AAE011AE50Q38663764-C782A59D-3219-4F60-89CC-94D07164E8DAQ38977535-1FA663C9-7143-4E66-A6CC-9C906372ECCDQ43683740-A446634A-33F2-48EA-8ECA-97DF416C921CQ45347829-D8FE4B6A-6C81-4980-AADC-5F67C16DE0E3Q45747685-BD3F4B95-E416-485D-ACF9-081AC41CD29DQ46848943-C4340FFB-58F3-4201-87A3-8ECF739CA0E7Q47421577-EA959928-FD22-4023-B1CB-C862F4204CA9Q47860238-C60FE09D-DDB2-4986-AB25-354B46FD15ACQ48465568-865876D2-4A2A-4101-BC91-AD9DCEB00989Q50796065-98EF9FB2-577A-4836-BB19-7728302E335AQ56774591-1777CFC2-8BA9-47A5-B0E0-CBE89BF6898CQ57359747-1DDE1B6B-D83E-4CF4-BC44-D9F07D5CA48D
P2860
U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
U.S. physician knowledge of th ...... : results of a national survey
@ast
U.S. physician knowledge of th ...... : results of a national survey
@en
U.S. physician knowledge of th ...... : results of a national survey
@nl
type
label
U.S. physician knowledge of th ...... : results of a national survey
@ast
U.S. physician knowledge of th ...... : results of a national survey
@en
U.S. physician knowledge of th ...... : results of a national survey
@nl
prefLabel
U.S. physician knowledge of th ...... : results of a national survey
@ast
U.S. physician knowledge of th ...... : results of a national survey
@en
U.S. physician knowledge of th ...... : results of a national survey
@nl
P2093
P356
P1476
U.S. physician knowledge of th ...... : results of a national survey
@en
P2093
Donna T Chen
G Caleb Alexander
Matthew K Wynia
Rachael M Moloney
P304
P356
10.1002/PDS.1825
P407
P577
2009-11-01T00:00:00Z